Catalyst overview
Research summary
This catalyst tracks a Failed discontinued for Batoclimab (IMVT-1401) in Thyroid Eye Disease . The expected timing is based on the latest available company guidance and may change.
Verification
Confirm timing and program details against the company announcement or filing.